肝移植中的供体特异性抗体
Donor-Specific Antibodies in Liver Transplantation.
作者信息
Nilles Kathy M, Levitsky Josh
机构信息
Department of Medicine and Surgery, Division of Gastroenterology and Hepatology, Comprehensive Transplant Center Northwestern University Feinberg School of Medicine Chicago IL.
出版信息
Clin Liver Dis (Hoboken). 2020 Feb 25;15(1):13-16. doi: 10.1002/cld.871. eCollection 2020 Jan.
Abstract
http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2046-2484/video/15-1-reading-nilles a video presentation of this article Answer questions and earn https://www.wileyhealthlearning.com/Activity/7025330/disclaimerspopup.aspx.
相似文献
1
Donor-Specific Antibodies in Liver Transplantation.肝移植中的供体特异性抗体
Clin Liver Dis (Hoboken). 2020 Feb 25;15(1):13-16. doi: 10.1002/cld.871. eCollection 2020 Jan.
2
Treating Alcohol Use Disorder in Chronic Liver Disease.治疗慢性肝病中的酒精使用障碍
Clin Liver Dis (Hoboken). 2020 Mar 26;15(2):77-80. doi: 10.1002/cld.881. eCollection 2020 Feb.
3
Nutritional Management of Cholestasis.胆汁淤积的营养管理
Clin Liver Dis (Hoboken). 2020 Feb 25;15(1):9-12. doi: 10.1002/cld.865. eCollection 2020 Jan.
4
Spotlight on Impactful Research: Long-Term Calcineurin Inhibitor Therapy and Brain Function in Patients After Liver Transplantation.聚焦有影响力的研究：肝移植术后患者长期钙调神经磷酸酶抑制剂治疗与脑功能
Clin Liver Dis (Hoboken). 2020 May 7;15(4):141-143. doi: 10.1002/cld.910. eCollection 2020 Apr.
5
Managing the Symptoms and Complications of Cholestasis.胆汁淤积症状及并发症的管理
Clin Liver Dis (Hoboken). 2020 Apr 4;15(3):120-124. doi: 10.1002/cld.901. eCollection 2020 Mar.
6
Isolated Elevated Bilirubin.孤立性胆红素升高
Clin Liver Dis (Hoboken). 2020 May 7;15(4):153-156. doi: 10.1002/cld.944. eCollection 2020 Apr.
7
Spotlight on Impactful Research: Utilization of Aspirin and Statin in Management of Coronary Artery Disease in Patients With Cirrhosis Undergoing Liver Transplant Evaluation.聚焦重大研究：阿司匹林和他汀类药物在接受肝移植评估的肝硬化患者冠状动脉疾病管理中的应用
Clin Liver Dis (Hoboken). 2020 Mar 26;15(2):69-70. doi: 10.1002/cld.899. eCollection 2020 Feb.
8
The Pathophysiology of Cholestasis and Its Relevance to Clinical Practice.胆汁淤积的病理生理学及其与临床实践的相关性。
Clin Liver Dis (Hoboken). 2020 Apr 4;15(3):110-114. doi: 10.1002/cld.894. eCollection 2020 Mar.
9
Novel Therapies for Managing Cholestasis.治疗胆汁淤积的新型疗法
Clin Liver Dis (Hoboken). 2020 Apr 4;15(3):95-99. doi: 10.1002/cld.886. eCollection 2020 Mar.
10
Checkpoint Inhibitors for the Treatment of Advanced Hepatocellular Carcinoma.用于治疗晚期肝细胞癌的检查点抑制剂
Clin Liver Dis (Hoboken). 2020 Mar 26;15(2):53-58. doi: 10.1002/cld.879. eCollection 2020 Feb.
引用本文的文献
1
Human leukocyte antigen and donor-specific antibodies in liver transplantation.肝移植中的人类白细胞抗原与供者特异性抗体
World J Gastroenterol. 2025 Jan 14;31(2):101620. doi: 10.3748/wjg.v31.i2.101620.
2
Immunology demystified: A guide for transplant hepatologists.免疫学揭秘：移植肝病学家指南
World J Transplant. 2024 Mar 18;14(1):89772. doi: 10.5500/wjt.v14.i1.89772.
3
Basics and Art of Immunosuppression in Liver Transplantation.肝移植中的免疫抑制基础与艺术
J Clin Exp Hepatol. 2024 May-Jun;14(3):101345. doi: 10.1016/j.jceh.2024.101345. Epub 2024 Jan 24.
4
Evolving Landscape in Liver Transplantation for Hepatocellular Carcinoma: From Stage Migration to Immunotherapy Revolution.肝细胞癌肝移植的发展态势：从分期迁移到免疫治疗革命
Life (Basel). 2023 Jul 14;13(7):1562. doi: 10.3390/life13071562.
本文引用的文献
1
Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report.移植中的致敏：风险评估（STAR）2017 工作组会议报告。
Am J Transplant. 2018 Jul;18(7):1604-1614. doi: 10.1111/ajt.14752. Epub 2018 May 22.
2
2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.2016 年肝移植病理学班夫工作组综合更新：抗体介导排斥反应的引入。
Am J Transplant. 2016 Oct;16(10):2816-2835. doi: 10.1111/ajt.13909. Epub 2016 Jul 14.
3
Prevention and treatment of liver allograft antibody-mediated rejection and the role of the 'two-hit hypothesis'.肝移植抗体介导性排斥反应的预防与治疗及“双打击假说”的作用
Curr Opin Organ Transplant. 2016 Apr;21(2):209-18. doi: 10.1097/MOT.0000000000000275.
4
Donor-specific antibodies and liver transplantation.供体特异性抗体与肝移植
Hum Immunol. 2016 Nov;77(11):1063-1070. doi: 10.1016/j.humimm.2016.02.006. Epub 2016 Feb 23.
5
Donor-Specific HLA Antibodies in Living Versus Deceased Donor Liver Transplant Recipients.活体与尸体供肝移植受者体内的供者特异性 HLA 抗体
Am J Transplant. 2016 Aug;16(8):2437-44. doi: 10.1111/ajt.13757. Epub 2016 Mar 23.
6
Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation.IgG3 亚类和结合 C1q 的供体特异性 HLA 同种抗体对肝移植排斥反应和存活的影响。
Am J Transplant. 2015 Apr;15(4):1003-13. doi: 10.1111/ajt.13153. Epub 2015 Mar 13.
7
Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation.预先形成的 II 类供体特异性抗体与肝移植后早期排斥反应的风险增加有关。
Liver Transpl. 2013 Sep;19(9):973-80. doi: 10.1002/lt.23687. Epub 2013 Jul 26.
8
De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients.在肝移植受者中，新产生的供体特异性 HLA 抗体可降低患者和移植物的存活率。
Am J Transplant. 2013 Jun;13(6):1541-8. doi: 10.1002/ajt.12212.
9
High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant.高平均荧光强度供体特异性抗 HLA 抗体与肝移植后慢性排斥反应相关。
Am J Transplant. 2011 Sep;11(9):1868-76. doi: 10.1111/j.1600-6143.2011.03593.x. Epub 2011 Jun 14.
10
Liver allograft antibody-mediated rejection with demonstration of sinusoidal C4d staining and circulating donor-specific antibodies.肝移植抗体介导的排斥反应，伴有窦状隙 C4d 染色和循环供体特异性抗体的证据。
Liver Transpl. 2011 Apr;17(4):357-68. doi: 10.1002/lt.22233.
Zotero 插件